Biological Information

Background Information:

Dopamine receptors belong to the superfamily of G protein-coupled seven transmembrane proteins. G-protein-coupled receptors constitute one of the major signal transduction systems in eukaryotic cells. Coding sequences for these receptors, in those regions believed to contribute to the agonist-antagonist binding site, are strongly conserved across mammalian species. Various members of the dopamine receptor family are generally classified as either ‘D1-like’ or ‘D2-like’. D1-like receptors comprise the D1 and D5 receptors, which activate adenylate cyclases via coupling to GS protein.

Family:

GPCR

Sub Family:

Dopamine

Class:

Class A

Protein Name:

D1

Uniprot Number:

P21728

Protein Aliases:

Dopamine D1 receptor

Gene Name:

DRD1

Gene ID:

1812

Accession Number:

NM_000794

Organism:

Human

Construct Details:

Full Length, Recombinant

Assay Information

Assay Type:

Biochemical

Assay Sub Type:

Binding

Detection Method:

Radiometry

Measured Response:

Scintillation

Testing Information

Procedure Summary:

This assay measures binding of [³H]SCH-23390 to human dopamine D1 receptors. CHO cells stably transfected with a plasmid encoding the human dopamine D1 receptor are used to prepare membranes in modified Tris-HCl pH 7.4 buffer using standard techniques. A 20 μg‡ aliquot of membrane is incubated with 1.4 nM [³H]SCH-23390 for 120 minutes at 37℃. Non-specific binding is estimated in the presence of 10 µM (+)-butaclamol. Membranes are filtered and washed 3 times and the filters are counted to determine [³H]SCH-23390 specifically bound. Compounds are screened at 10 µM.
Note: ‡Membrane protein may change from lot to lot, the concentration used will be adjusted if necessary.

Ligand:

[³H] SCH-23390

Ligand Kd (nM):

1.4

Ligand Concentration:

1.4 nM

Non Specific:

10 µM (+)-Butaclamol

Incubation:

120 min at 37°C

Control Inhibitor:

R(+)-SCH-23390

Criteria For Significance:

≥ 50% of max stimulation or inhibition

Test Concentration / Dose:

Suggested concentration for initial testing is 10 uM

Test Sample Requirements:

Minimum for 1) Screen: 25 μl of 10 mM stock -OR- 1 mg (pre-weighed). 2) Dose Response: 60 μl of 10 mM stock -OR- 1 mg (pre-weighed).

Minimum Order Quantity:

2

Turnaround Time

Standard:

10 Business Days

Reference Compound Data

PubChem ID

901

Name

Acetylcholine

Measurement

4.1μM - IC50

PubChem ID

1242

Name

SKF 38393

Measurement

0.094μM - IC50

PubChem ID

2726

Name

Chlorpromazine

Measurement

0.12μM - IC50

PubChem ID

2818

Name

Clozapine

Measurement

0.14μM - IC50

PubChem ID

3559

Name

Haloperidol

Measurement

0.13μM - IC50

PubChem ID

5265

Name

Spiperone

Measurement

1.3μM - IC50

PubChem ID

37459

Name

(+)-Butaclamol

Measurement

0.0068μM - IC50

PubChem ID

5281881

Name

Cis-Flupentixol

Measurement

0.0013μM - IC50

PubChem ID

24277910

Name

R(+)-SCH-23390

Measurement

0.0014μM - IC50

PubChem ID

Name

S(-)-Sulpiride

Measurement

>10μM - IC50

Clinical Relevance

Therapeutic Area:

CNS/Addiction/Pain

Adverse / Beneficial Action:

D1 receptor agonism may be of therapeutic benefit in the treatment of Parkinsons disease as well as induce dyskinesia, extreme arousal, locomotor activation, vasodilation and hypotension.

Additional Information

Brand:

LeadHunter

Testing Location:

Taiwan - Taipei

RELATED SOLUTIONS

Item: 310000
Item: PP16
Item: PP68
Item: PP70
Item: PP89
Item: PP115
Item: PP116
Item: PP223
Item: PP241
Item: 310000-0
Item: 310000-1